The Beauty Health Company (NASDAQ:SKIN) Given Average Recommendation of “Reduce” by Analysts

Shares of The Beauty Health Company (NASDAQ:SKIN) have been assigned an average rating of “Reduce” from the eleven ratings firms that are presently covering the stock, Marketbeat Ratings reports. Three research analysts have rated the stock with a sell rating, seven have given a hold rating and one has given a buy rating to the company. The average twelve-month target price among brokers that have issued a report on the stock in the last year is $2.46.

A number of brokerages recently commented on SKIN. Canaccord Genuity Group reduced their price objective on shares of Beauty Health from $2.00 to $1.25 and set a “hold” rating for the company in a research report on Monday, August 12th. Stifel Nicolaus reduced their price objective on shares of Beauty Health from $4.00 to $2.00 and set a “hold” rating for the company in a research report on Friday, July 26th. Finally, Piper Sandler restated an “underweight” rating and issued a $1.00 price objective (down previously from $1.50) on shares of Beauty Health in a research report on Friday, August 9th.

Insider Transactions at Beauty Health

In related news, Chairman Brent L. Saunders acquired 40,450 shares of the firm’s stock in a transaction that occurred on Monday, August 12th. The shares were acquired at an average price of $1.08 per share, with a total value of $43,686.00. Following the completion of the purchase, the chairman now directly owns 5,921,769 shares in the company, valued at $6,395,510.52. The purchase was disclosed in a document filed with the SEC, which is available through this link. Insiders own 41.00% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in the company. Price T Rowe Associates Inc. MD raised its stake in Beauty Health by 8.6% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 75,281 shares of the company’s stock valued at $335,000 after purchasing an additional 5,934 shares during the last quarter. HighMark Wealth Management LLC acquired a new position in Beauty Health in the 1st quarter valued at about $31,000. 180 Wealth Advisors LLC raised its stake in Beauty Health by 14.9% in the 1st quarter. 180 Wealth Advisors LLC now owns 81,285 shares of the company’s stock valued at $361,000 after purchasing an additional 10,566 shares during the last quarter. SageView Advisory Group LLC acquired a new position in Beauty Health in the 1st quarter valued at about $60,000. Finally, Aigen Investment Management LP raised its stake in Beauty Health by 88.7% in the 4th quarter. Aigen Investment Management LP now owns 31,865 shares of the company’s stock valued at $99,000 after purchasing an additional 14,974 shares during the last quarter. Institutional investors and hedge funds own 93.26% of the company’s stock.

Beauty Health Stock Performance

Shares of SKIN stock opened at $1.44 on Wednesday. Beauty Health has a 1 year low of $0.91 and a 1 year high of $6.25. The firm has a market cap of $178.03 million, a price-to-earnings ratio of -2.06 and a beta of 0.95. The stock’s 50-day moving average is $1.62 and its two-hundred day moving average is $2.48. The company has a debt-to-equity ratio of 7.96, a quick ratio of 5.47 and a current ratio of 6.49.

Beauty Health (NASDAQ:SKIN) last announced its earnings results on Thursday, August 8th. The company reported ($0.10) earnings per share for the quarter, missing the consensus estimate of ($0.05) by ($0.05). Beauty Health had a negative return on equity of 4.57% and a negative net margin of 22.86%. The business had revenue of $90.60 million for the quarter, compared to analyst estimates of $98.46 million. Analysts predict that Beauty Health will post -0.2 earnings per share for the current year.

Beauty Health Company Profile

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health.